About Acute myeloid leukemia with t(8;21)(q22;q22) translocation
Acute myeloid leukemia with t(8;21)(q22;q22) translocation is a rare disease catalogued by Orphanet (ORPHA:102724). It is associated with the RUNX1, FLT3, CEBPA genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Acute myeloid leukemia with t(8;21)(q22;q22) translocation trials.
Search ClinicalTrials.gov for "Acute myeloid leukemia with t(8;21)(q22;q22) translocation" or filter by Orphanet code ORPHA:102724 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Acute myeloid leukemia with t(8;21)(q22;q22) translocation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Acute myeloid leukemia with t(8;21)(q22;q22) translocation. Updated daily.